Technical Briefing: Pfizer, Merck & Co., AbbVie, and Zogenix

         Technical Briefing: Pfizer, Merck & Co., AbbVie, and Zogenix

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, July 24, 2013

LONDON, July 24, 2013 /PRNewswire/ --

On Tuesday, July 23, 2013, shares in major drug manufacturers ended on a mixed
note, tracking the broader market. The major movers in the industry included
Pfizer Inc. (NYSE: PFE), Merck & Co. Inc. (NYSE: MRK), AbbVie Inc. (NYSE:
ABBV), and Zogenix Inc. (NASDAQ: ZGNX). All these companies are tracked by
AAAResearchReports.com. Free technical research reports on PFE, MRK, ABBV, and
ZGNX can be accessed by signing up at:

http://www.aaaresearchreports.com/register/ 

Shares in Pfizer Inc. edged higher on Tuesday, extending their gains from
previous trading sessions. The company's shares fluctuated between $29.32 and
$29.53 before finishing the day 0.24% higher at $29.42. A total of 27.28
million shares were traded which is below the daily average volume of 79.54
million. The stock has gained 3.26% in the last three trading sessions and
3.37% in the last one month as compared to a gain of 0.18% and 6.28% in the
S&P 500 during the respective periods. Download free report on PFE upon
registration at:

http://www.AAAResearchReports.com/PFE072413.pdf

Merck & Co. Inc.'s stock edged higher on Tuesday, ending the session at
$47.93, up 0.44% from its previous closing price. The company's shares
fluctuated between $47.54 and $48.22. A total of 9.24 million shares were
traded which is below the daily average volume of 15.62 million. The company's
shares have gained 1.12% in the last three trading sessions and 1.98% in the
last one month. MRK technical report can be accessed for free by signing up
at:

http://www.AAAResearchReports.com/MRK072413.pdf

Shares in AbbVie Inc. moved lower on Tuesday, reversing all of their gains
from previous trading sessions. The company's shares fluctuated between $44.23
and $45.09 before finishing the day 1.47% lower at $44.31. A total of 3.54
million shares were traded which is below the daily average volume of 4.61
million. The company's shares have fallen by 0.02% in the last three trading
sessions. Despite Tuesday's pullback, the stock is trading above its 50-day
and 200-day moving averages. A free report on ABBV can be accessed by
registering at:

http://www.AAAResearchReports.com/ABBV072413.pdf

Zogenix Inc.'s stock fell sharply on Tuesday, extending its losses from
previous trading sessions. The company's shares ended the day 1.92% lower at
$1.53 after oscillating between $1.52 and $1.58. A total of 252,925 shares
were traded which is below the daily average volume of 479,069. The company's
shares have fallen by 5.56% in the last three trading sessions,
underperforming the S&P 500. Register with AAA Research Reports and download
research on ZGNX for free at:

http://www.AAAResearchReports.com/ZGNX072413.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: AAAresearchreports.com Phone #: +1(646)396-9126
 
Press spacebar to pause and continue. Press esc to stop.